Snapshot Highlights
- Leading authority in Cardiology and Coronary Intensive Care Unit.
- Distinguished career spanning over two decades of dedicated medical practice.
- Significant contributions to cardiac research with numerous peer-reviewed publications.
- Held professorial roles at esteemed institutions, including Istanbul University and Gaziantep University.
- Recognized for leadership as Chief Physician and Head of Department in prominent hospitals.
Dr. MUSTAFA HAKAN DINCKAL
Professional Experience
Dr. Mustafa Hakan Dinckal brings extensive experience in Cardiology and the Coronary Intensive Care Unit, demonstrating a profound commitment to cardiovascular health. His career highlights include impactful roles within the Acıbadem Health Group, demonstrating continuous dedication to patient care and advancement in the field.
- Acıbadem Health Group (2022 – Present)
- Member of Faculty at Tekirdağ Namık Kemal University (2019 – 2022)
- Professor, Department of Cardiology, Istanbul University/Cerrahpaşa Faculty of Medicine (2015 – 2017)
- Chief Physician, Bakırköy Dr. Sadi Konuk Training and Research Hospital (2015 – 2016)
- Head of Department, Bağcılar Training and Research Hospital (2008 – 2015)
- Associate Professor, Department of Cardiology, Gaziantep University Faculty of Medicine (2004 – 2005)
- Assistant Professor, Department of Cardiology, Gaziantep University Faculty of Medicine (2001 – 2004)
Education
Dr. Dinckal’s foundational medical education was completed at Ege University Faculty of Medicine in 1992. He further specialized in Cardiology at Kartal Koşuyolu High Specialization Training and Research Hospital, achieving this distinction in 1997.
- Cardiology Specialization, Kartal Koşuyolu High Specialization Training and Research Hospital (1997)
- Faculty of Medicine, Ege University (1992)
Areas of Expertise & Research
Dr. Dinckal’s expertise encompasses a broad spectrum of cardiovascular conditions. His research interests are reflected in numerous publications, investigating critical areas such as cerebral emboli predictors in infective endocarditis, the role of copeptin in hypertrophic cardiomyopathy outcomes, and the association of muscle strength and visceral fat with STEMI outcomes. He has also explored the relationship between degenerative scoliosis and aortic parameters, as well as the prognostic value of platelet and neutrophil-to-lymphocyte ratios in acute myocardial infarction.
Professional Memberships
As a respected member of the medical community, Dr. Dinckal is affiliated with the Turkish Cardiology Association, underscoring his commitment to advancing cardiac care and adhering to the highest professional standards.
- Turkish Cardiology Association
Publications
Dr. Dinckal is an active contributor to medical literature, with significant publications in peer-reviewed journals. These works address crucial aspects of cardiovascular disease management and patient outcomes, including research on cerebral emboli, copeptin levels in hypertrophic cardiomyopathy, no-reflow phenomena in STEMI, and the impact of patient characteristics on statin discontinuation.
- Cerebral emboli as the predictor of mortality in patients with “definite” infective endocarditis. Medicine Science | International Medical Journal, 10(3), 839-845. (2021)
- Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy. Clinical Cardiology, 40(1), 32-37. (2017)
- Lower Muscle Strength and Increased Visceral Fat Associated With No-reflow and High Gensini Score in STEMI. Clinical and Applied Thrombosis/Hemostasis, 23(4), 367-373. (2017)
- Adult degenerative scoliosis associated with increased aortic diameter and plaque burden and composition. Vascular, 24(3), 315-322. (2016)
- Patient characteristics and statin discontinuation related factors during treatment of hypercholesterolemia an observational non interventional study. Turkish Society of Cardiology Archives-Archives of the Turkish Society of Cardiology, 44(1), 53-64. (2015)
- Lower Muscle Strength and Increased Visceral Fat Associated With No reflow and High Gensini Score in STEMI. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. (2015)
- Contribution of platelets indices in the development of contrast induced nephropathy. BLOOD COAGULATION & FIBRINOLYSIS, 26(3), 246-249.
- Increased Transforming Growth Factor Levels Associated With Cardiac Adverse Events in Hypertrophic Cardiomyopathy. CLINICAL CARDIOLOGY, 38(6), 371-377.
- Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention. PLATELETS, 26(7), 638-644.
- Neutrophil to Lymphocyte Ratio is Related to Stent Thrombosis and High Mortality in Patients With Acute Myocardial Infarction. ANGIOLOGY, 66(6), 545-552. (2015)